Key Requirements for Transitioning to Serialized T2 Data

This guide outlines the key requirements for transitioning from non-serialized T3 data to serialized T2 data as mandated by the Drug Supply Chain Security Act (DSCSA) 2023. It emphasizes the necessity for health industry companies, including drug manufacturers, wholesalers, hospitals, and retail pharmacies, to exchange serialized Transaction Information (TI) and Transaction Statement (TS) data electronically at the package level by the compliance deadline of November 27, 2023. The document explains the shift from Electronic Data Interchange (EDI) to Electronic Product Code Information Services (EPCIS), which is a global GS1 Standard. It discusses the challenges of connectivity and the importance of seamless system integration with trading partners. The guide also details the capabilities required for managing serialization, including inventory status and exception management, and highlights the flexibility of the TraceLink OPUS Solution Designer to customize solutions according to specific supply chain needs. The content is based on insights from a recent webinar on DSCSA compliance.